National
Mulago gets equipment worth sh35m
Publish Date: Jun 04, 2014
Mulago gets equipment worth sh35m
(L-R) GSK country manager Nathan Wasolo; Mulago principal anesthetist Paul Masereka, Jaliat Nambalirwa and sister Mary Kemigisha from Mulago displaying the donated infusion pumps.Photo/Violet Nabatanzi
  • mail
  • img
newvision

By Juliet Waiswa

Mulago national referral hospital has received equipment worth Sh 35m to manage highly sensitive medications to patients.
 

The equipment handed over to the principal Anesthetist includes infusion pumps. The pumps will help anesthetists to maintain a constant flow of the pain killers to patients throughout surgery.
 

An infusion pump is a medical device used to deliver fluids into a patient’s body in a controlled manner.
 

Infusion pumps may be capable of delivering fluids in large or small amounts, and may be used to deliver nutrients or medications – such as insulin, chemotherapy drugs, and pain relievers.
 

Speaking during a press conference in Kampala, the principal Anesthetist Paul Masereka said, “Such pumps help us to maintain the patient under anesthesia even if the operation is taking long.”
 

He added that, anesthetists will use less gas during the operations and hence hospitals will spend less money on purchasing gases.
 

The infusion pumps were donated by world renowned pharmaceutical company GlaxoSmithKline (GSK) as part of its patient focused initiatives, which aim to ensure that the patient receives the best treatment and care through technical support and skills transfer.
 

The syringe pumps handed over by GSK country manager Nathan Wasolo are high precision equipment used to deliver measured medications and other fluids with high level of accuracy for a given period.
 

GSK has committed to reinvest 20% of its net profits to strengthening the healthcare system in developing countries that it operates in, including Uganda.

In this initiative, GSK is partnering with Amref Health Africa in an e-learning module that up-scale the skills of midwives.
 

In addition, GSK together with the government of Uganda, is fast-tracking a schools deworming programme that will see hundreds of children provided with deworming medication Albendazole which is also effective in elimination of Elephantiasis.
 

 

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
14 killed in DR Congo machete attack
THE incursion by the Ugandan rebel group ADF took place overnight in the town of Kampi ya Chui....
Businessman sues UNRA over Entebbe Expressway
A businessman has dragged UNRA to court seeking sh5b in damages for loss of business and the inconvenience over the construction of the Entebbe Expressway....
US Commander of Africa Forces visits
President Yoweri Museveni has said that the main challenge in Somalia today was clan-related issues. The President made the remarks at State House Entebbe in a meeting with the United States of America Commander of Africa Forces, General David Rodriguez....
Museveni hails Uganda-North Korea ties
President Yoweri Museveni describes the North Koreans as friends who have helped Uganda for a long time on visit of one of its leaders....
Slain Unilever boss mourned
Speaker after speaker described Makanga as a smart, classy, humble, respectful, joyful, hardworking man at his funeral in Kampala....
Muntu warns Mafabi, Nabila over media exchanges
ACCORDING to John Kikonyogo, the party spokesperson, Muntu said discussing the issues in the media was affecting the image of the party...
Should the absence of bride price prevent couples from wedding?
Yes
No
Can't Say
follow us
subscribe to our news letter